Where does Renalsense Ltd. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Renalsense Ltd. ranks #42,628 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Renalsense Ltd. hold?

Renalsense Ltd. holds 6 US utility patents granted between 2015 and 2023, spanning 7 technology areas.

What is Renalsense Ltd.'s Innovation Score?

Renalsense Ltd. has an Innovation Score of 44.4 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Renalsense Ltd. focus on?

Renalsense Ltd.'s top technology area is G01F (Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume) with 4 patents, ranking #229 of 1,205 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Renalsense Ltd.'s patent grant rate increasing or decreasing?

Renalsense Ltd.'s recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Renalsense Ltd.'s patents?

Renalsense Ltd.'s patents average 13.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Renalsense Ltd. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Renalsense Ltd.

USPTO PatentsView assignee record - 6 granted patents across 7 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01F (Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Renalsense ranks #42,628 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 7 technology areas.

#42,628
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.4/100): 13.8
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R42628 · Foreign Corporation #42,628 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 6 grants
LOWER-Q #42,628/49,997
PHOTO-FINISH ReliantHeart
CPC-NARROW G01F · 7 areas
INNOV-PAR 44.4/100
CLAIMS-RICH 13.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: ReliantHeart, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Renalsense’s 44.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (15%) Velocity 20.0 pts (45%) Breadth 9.4 pts (21%) Claim depth 8.3 pts (19%)

Qualcomm Incorporated · highest

85
Renalsense · this assignee

44
3D Lighting… · lowest

7

What this shows Renalsense's Innovation Score is 44.4/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Renalsense?

Each dot is one of Renalsense’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Renalsense’s own 13.8 claims/patent is at or below the 17.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Renalsense vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Renalsense's grants concentrate

Renalsense Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 66.7% of grants classified under G01F (Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume). Peak complete grant year is 2022 (2 grants) versus a trough of 1 in 2015. By volume, Renalsense sits between ReliantHeart, Inc. and Resolute Patents, LLC.

Renalsense's three-year grant acceleration

Renalsense Ltd. shows 3 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Reliantheart

6
Relmada Therapeut…

6
Relola

6
Remcon Plastics I…

6
Renesas Design Ne…

6
Renesas Semicondu…

6
Renovacare Scienc…

6
Resolute Patents

6
Renalsense ◀

6

What this shows Renalsense holds 6 patents at rank #42,657, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Renalsense

By rank, the assignees closest to #42,657 in granted patent volume.

Leaders in G01F (Measuring Volume)

Other assignees with the most granted patents in Renalsense's primary technology class.

Renalsense's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Renalsense Ltd. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	16.7%
2018	1	16.7%
2019	1	16.7%
2022	2	33.3%
2023	1	16.7%

Which technologies does Renalsense Ltd. patent most?

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 4

A61B - DIAGNOSIS; SURGERY; Identification 3

G01D - Measuring NOT Specially Adapted FOR A Specific VARIABLE; Arrangements FOR Measuring TWO OR More Variables NOT Covered IN A Single Other SUBCLASS; Tariff Metering APPARATUS; Measuring OR Testing NOT Otherwise Provided FOR 2

G01K - Measuring TEMPERATURE; Measuring Quantity OF HEAT; Thermally-sensitive Elements NOT Otherwise Provided FOR 2

G01P - Measuring Linear OR Angular Speed, Acceleration, Deceleration, OR SHOCK; Indicating Presence, Absence, OR Direction, OF Movement 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Renalsense Ltd.'s patent record in context - here's where to go next.

Renalsense Ltd.'s lead technology class is G01F (Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume), 66.7% of its portfolio - see every assignee active in that class. Explore G01F
Ranked #42,628 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Renalsense Ltd. against ReliantHeart, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.